Gaofeng F. Chen
Key Laboratory Of Liver And Kidney Diseases
Shuguang, 201203, China
Shuguang, 201203, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Salvianolic acid B ameliorates metabolic dysfunction-associated steatohepatitis in mice by inhibiting hepatocyte ferroptosis via regulation of the SIRT1/p53 axis.
Journal: Free radical biology & medicine
Published: January 15, 2026
Fuzheng Huayu formula attenuates ductular reaction and liver fibrosis potentially through suppressing Gli1 pathway.
Journal: Journal of ethnopharmacology
Published: December 23, 2025
Noninvasive Detection of MASH and Fibrotic Burden Using Ultrasound-Derived LIID and LSM in MASLD: A Multicenter Study.
Journal: Journal of gastroenterology and hepatology
Published: December 20, 2025
Synergistic amelioration of cholestatic liver fibrosis by combined total astragalus saponins and AAV8.Numb-Exon3 through modulation of hepatic progenitor cell differentiation.
Journal: Frontiers in pharmacology
Published: December 07, 2025
Isoastragaloside II modulates PPAR-α/FXR signaling and bile acid metabolism to ameliorate cholestatic liver diseases (CLD).
Journal: European journal of pharmacology
Published: December 01, 2025
Xiayuxue decoction alleviates MASH by regulating gut microbiota, bile acid metabolism, and m6A modification.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: September 25, 2025
Comparative transcriptomic analysis reveals STAT3 as a candidate gene involved in aristolochic acid I-induced hepatorenal toxicity.
Journal: Toxicology letters
Published: July 11, 2025
Interventional effect of bone marrow mesenchymal stem cell transplantation with different doses of X-ray irradiation induced hepatic injury in mice
Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Published: December 03, 2024
Study on the mechanism of Fuzheng Huayu formula against biliary fibrosis in mice
Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Published: November 28, 2024
Oxymatrine relieves non-alcoholic fatty liver disease by promoting sirtuin 1/adenosine 5'-monophosphate-activated protein kinase pathway and peroxisome proliferator activated receptor alpha-mediated hepatic fatty acid oxidation.
Journal: European journal of pharmacology
Published: October 14, 2024
Oxymatrine reduces hepatic lipid synthesis in rat model of nonalcoholic steatohepatitis by regulating Sirt1/AMPK and LXR/Plin2/SREBP-1c pathways.
Journal: Chemico-biological interactions
Published: October 08, 2024
Characteristics of liver volume and pathological changes with different stages of liver fibrosis in chronic liver disease
Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Published: July 04, 2024
Last Updated: 09/26/2026